Your browser doesn't support javascript.
loading
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL.
Hochhaus, Andreas; Réa, Delphine; Boquimpani, Carla; Minami, Yosuke; Cortes, Jorge E; Hughes, Timothy P; Apperley, Jane F; Lomaia, Elza; Voloshin, Sergey; Turkina, Anna; Kim, Dong-Wook; Abdo, Andre; Fogliatto, Laura Maria; le Coutre, Philipp; Sasaki, Koji; Kim, Dennis Dong Hwan; Saussele, Susanne; Annunziata, Mario; Chaudhri, Naeem; Chee, Lynette; García-Gutiérrez, Valentin; Kapoor, Shruti; Allepuz, Alex; Quenet, Sara; Bédoucha, Véronique; Mauro, Michael J.
Afiliação
  • Hochhaus A; Universitätsklinikum Jena, Jena, Germany. andreas.hochhaus@med.uni-jena.de.
  • Réa D; Adult Hematology and INSERM CIC1427, Hôpital Saint-Louis, Paris, France.
  • Boquimpani C; HEMORIO, State Institute of Hematology Arthur de Siquiera Cavalcanti, Rio de Janeiro, Brazil.
  • Minami Y; Oncoclínica Centro de Tratamento Oncológico, Rio de Janeiro, RJ, Brazil.
  • Cortes JE; National Cancer Center Hospital East, Kashiwa, Japan.
  • Hughes TP; Georgia Cancer Center, Augusta, GA, USA.
  • Apperley JF; South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, SA, Australia.
  • Lomaia E; Centre for Haematology Imperial College London, London, UK.
  • Voloshin S; Almazov National Medical Research Centre, St. Petersburg, Russia.
  • Turkina A; Russian Research Institute of Hematology and Transfusiology, St. Petersburg, Russia.
  • Kim DW; National Medical Research Center for Hematology, Moscow, Russia.
  • Abdo A; Uijeongbu Eulji Medical Center, Geumo-dong, Uijeongbu-si, South Korea.
  • Fogliatto LM; Instituto do Câncer do Estado de São Paulo (ICESPSP), São Paulo, Brazil.
  • le Coutre P; Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil.
  • Sasaki K; Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Kim DDH; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Saussele S; Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Annunziata M; III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany.
  • Chaudhri N; Division of Hematology, AORN Cardarelli, Naples, Italy.
  • Chee L; King Faisal Specialist Hospital & Research Center, Riyadh, Kingdom of Saudi Arabia.
  • García-Gutiérrez V; Peter MacCallum Cancer Center and The Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Kapoor S; Servicio de Hematología, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
  • Allepuz A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Quenet S; Novartis Pharma AG, Basel, Switzerland.
  • Bédoucha V; Novartis Pharma AG, Basel, Switzerland.
  • Mauro MJ; Novartis Pharma AG, Basel, Switzerland.
Leukemia ; 37(3): 617-626, 2023 03.
Article em En | MEDLINE | ID: mdl-36717654
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide de Fase Crônica Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide de Fase Crônica Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido